Login Register Cart 0
Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Cheminformatics Screening of Phytochemicals Targeting Diverse Potential Receptors to Elicit Antiviral Properties

Author(s): Ravi Kumar*, Garima Gupta, Aditi Mohan and Madhu Gupta

Volume 5, Issue 3, 2024

Published on: 20 November, 2023

Article ID: e161123223580 Pages: 19

DOI: 10.2174/0126667975270644231107110626

Price: $65

Abstract

Objective: Recently, the COVID-19 (coronavirus disease) pandemic caused by SARSCoV- 2 (severe acute respiratory syndrome coronavirus) gave rise to a public health emergency worldwide. Similarly, other viruses like HIV (Human Immunodeficiency Virus)/AIDS (acquired immunodeficiency syndrome), Zika, Ebola, and Influenza and their mutants have called for an urgent need for a Broad-spectrum antiviral drug, inhibiting the infection by targeting the common essential components of different viruses.

Methods: Based on ancient medicinal knowledge, we made an attempt through molecular docking analysis to explore different phytochemical compounds against well-recognized viral receptors.

Results: A total of 29 phytochemicals were virtually examined against 4 targets essential in the life cycle of viral infection: CD147 (Cluster of Differentiation 147), CD209L (Cluster of Differentiation 209 Lectin), eIF4A (Eukaryotic Initiation Factor 4A), and RdRp (RNA-dependent RNA polymerase). Providentially, Berbamine was identified as the best-hit lead molecule based on binding energies, conventional hydrogen bonding numbers, and non-covalent interactions. It exhibited binding energies as -8.3 kcal/mol with CD147, -8.2 kcal/mol with CD209L, -9.5 kcal/mol with eIF4A, and - 10.5 kcal/mol with RdRp. Additionally, in-silico drug likeliness (Lipinski’s rule) and ADME studies depict high bioavailability and gastrointestinal absorption and follow Lipinski’s rule.

Conclusion: The data presented by our study illustrate phytochemicals from the selected plants that could target conserved viral components shared across multiple viruses. Berbamine can be designed as a possible drug to target Broad-Spectrum viruses, limiting the effectiveness of different viruses.

Graphical Abstract

[1]
Culliton BJ. Emerging viruses, emerging threat. Science 1990; 247(4940): 279-80.
[http://dx.doi.org/10.1126/science.2153314] [PMID: 2153314]
[2]
Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798): 265-9.
[http://dx.doi.org/10.1038/s41586-020-2008-3] [PMID: 32015508]
[3]
Sabbatani S, Fiorino S. [The antonine plague and the decline of the roman empire]. Infez Med 2009; 17(4): 261-75.
[PMID: 20046111]
[4]
Jester B, Uyeki TM, Jernigan DB, Tumpey TM. Historical and clinical aspects of the 1918 H1N1 pandemic in the United States. Virology 2019; 527: 32-7.
[http://dx.doi.org/10.1016/j.virol.2018.10.019] [PMID: 30453209]
[5]
Hsu LY, Chia PY, Lim JFY. The novel coronavirus (SARS-CoV-2) pandemic. Ann Acad Med Singap 2020; 49(3): 105-7.
[http://dx.doi.org/10.47102/annals-acadmedsg.202051] [PMID: 32200398]
[6]
Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis. Lancet Microbe 2021; 2(1): e13-22.
[http://dx.doi.org/10.1016/S2666-5247(20)30172-5] [PMID: 33521734]
[7]
Uyeki TM, Cox NJ. Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med 2013; 368(20): 1862-4.
[http://dx.doi.org/10.1056/NEJMp1304661] [PMID: 23577629]
[8]
Zammarchi L, Tappe D, Fortuna C, et al. Zika virus infection in a traveller returning to Europe from Brazil, March 2015. Euro Surveill 2015; 20(23): 21153.
[http://dx.doi.org/10.2807/1560-7917.ES2015.20.23.21153] [PMID: 26084316]
[9]
Colavita F, Biava M, Castilletti C, et al. Inflammatory and humoral immune response during Ebola virus infection in survivor and fatal cases occurred in Sierra leone during the 2014–2016 outbreak in West Africa. Viruses 2019; 11(4): 373.
[http://dx.doi.org/10.3390/v11040373] [PMID: 31018522]
[10]
Ang BSP, Lim TCC, Wang L. Nipah virus infection. J Clin Microbiol 2018; 56(6): e01875-17.
[http://dx.doi.org/10.1128/JCM.01875-17] [PMID: 29643201]
[11]
Alempic JM, Lartigue A, Goncharov AE, et al. An update on eukaryotic viruses revived from ancient permafrost. Viruses 2023; 15(2): 564.
[http://dx.doi.org/10.3390/v15020564] [PMID: 36851778]
[12]
Rigou S, Santini S, Abergel C, Claverie JM, Legendre M. Past and present giant viruses diversity explored through permafrost metagenomics. Nat Commun 2022; 13(1): 5853.
[http://dx.doi.org/10.1038/s41467-022-33633-x] [PMID: 36207343]
[13]
Samji T. Influenza A: understanding the viral life cycle. Yale J Biol Med 2009; 82(4): 153-9.
[PMID: 20027280]
[14]
Sager G, Gabaglio S, Sztul E, Belov GA. Role of host cell secretory machinery in Zika virus life cycle. Viruses 2018; 10(10): 559.
[http://dx.doi.org/10.3390/v10100559] [PMID: 30326556]
[15]
Biswas R, Chowdhury N, Mukherjee R, Bagchi A. Identification and analyses of natural compounds as potential inhibitors of TRAF6-Basigin interactions in melanoma using structure-based virtual screening and molecular dynamics simulations. J Mol Graph Model 2018; 85: 281-93.
[http://dx.doi.org/10.1016/j.jmgm.2018.09.008] [PMID: 30253283]
[16]
Amraei R, Yin W, Napoleon MA, et al. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2. ACS Cent Sci 2021; 7(7): 1156-65.
[http://dx.doi.org/10.1021/acscentsci.0c01537] [PMID: 34341769]
[17]
Machitani M, Yasukawa M, Nakashima J, Furuichi Y, Masutomi K. RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19. Cancer Sci 2020; 111(11): 3976-84.
[http://dx.doi.org/10.1111/cas.14618] [PMID: 32805774]
[18]
Shen L, Pelletier J. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products. Nat Prod Rep 2020; 37(5): 609-16.
[http://dx.doi.org/10.1039/C9NP00052F] [PMID: 31782447]
[19]
a) Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. Int J Biol Sci 2020; 16(10): 1708.;
b) Samji P, Rajendran MK, Warrier VP. SARS-CoV-2 and its predicted potential natural inhibitors: A review and perspective. Coronaviruses 2021; 2(5): 7-20.
[20]
Moheimani F, Koops J, Williams T, et al. Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics. Respir Res 2018; 19(1): 145.
[http://dx.doi.org/10.1186/s12931-018-0851-7] [PMID: 30068332]
[21]
Jeffers SA, Hemmila EM, Holmes KV. Human coronavirus 229E can use CD209L (L-SIGN) to enter cells. In: The Nidoviruses: Toward Control of SARS and other Nidovirus Diseases. Springer US 2006; pp. 265-9.
[http://dx.doi.org/10.1007/978-0-387-33012-9_44]
[22]
Pushkarsky T, Zybarth G, Dubrovsky L, et al. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proceedings of the National Academy of Sciences. 6360-5.
[http://dx.doi.org/10.1073/pnas.111583198]
[23]
Feng P, Everly DN Jr, Read GS. mRNA decay during herpes simplex virus (HSV) infections: protein-protein interactions involving the HSV virion host shutoff protein and translation factors eIF4H and eIF4A. J Virol 2005; 79(15): 9651-64.
[http://dx.doi.org/10.1128/JVI.79.15.9651-9664.2005] [PMID: 16014927]
[24]
Bekheit MS, Panda SS, Girgis AS. Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2. Eur J Med Chem 2023; 252: 115292.
[http://dx.doi.org/10.1016/j.ejmech.2023.115292] [PMID: 36965227]
[25]
Sen S, Chakraborty R. Toward the integration and advancement of herbal medicine: A focus on traditional Indian medicine. Botanics 2015; 5: 33-44.
[http://dx.doi.org/10.2147/BTAT.S66308]
[26]
Irfan A, Imran M, Khalid N, et al. Isolation of phytochemicals from Malva neglecta Wallr and their quantum chemical, molecular docking exploration as active drugs against COVID-19. J Saudi Chem Soc 2021; 25(12): 101358.
[http://dx.doi.org/10.1016/j.jscs.2021.101358]
[27]
Fuzimoto AD. An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment. J Integr Med 2021; 19(5): 375-88.
[http://dx.doi.org/10.1016/j.joim.2021.07.003] [PMID: 34479848]
[28]
Das SK, Mahanta S, Tanti B, Tag H, Hui PK. Identification of phytocompounds from Houttuynia cordata Thunb. as potential inhibitors for SARS-CoV-2 replication proteins through GC-MS/LC-MS characterization, molecular docking and molecular dynamics simulation. Mol Divers 2022; 26(1): 365-88.
[http://dx.doi.org/10.1007/s11030-021-10226-2] [PMID: 33961167]
[29]
Li BH, Li ZY, Liu MM, Tian JZ, Cui QH. Progress in traditional Chinese medicine against respiratory viruses: a review. Front Pharmacol 2021; 12: 743623.
[http://dx.doi.org/10.3389/fphar.2021.743623] [PMID: 34531754]
[30]
Malekmohammad K, Rafieian-Kopaei M. Mechanistic aspects of medicinal plants and secondary metabolites against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Curr Pharm Des 2021; 27(38): 3996-4007.
[http://dx.doi.org/10.2174/1381612827666210705160130] [PMID: 34225607]
[31]
Wang H, Jia Q, Feng J, et al. Establishment of angiotensin-converting enzyme 2 and cluster of differentiation 147 dual target cell membrane chromatography based on SNAP-tag technology for screening anti severe acute respiratory syndrome coronavirus 2 active components. J Chromatogr A 2023; 1693: 463903.
[http://dx.doi.org/10.1016/j.chroma.2023.463903] [PMID: 36870232]
[32]
Varga N, Sutkeviciute I, Ribeiro-Viana R, et al. A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus. Biomaterials 2014; 35(13): 4175-84.
[http://dx.doi.org/10.1016/j.biomaterials.2014.01.014] [PMID: 24508075]
[33]
Canini A, Alesiani D, D’Arcangelo G, Tagliatesta P. Gas chromatography–mass spectrometry analysis of phenolic compounds from Carica papaya L. leaf. J Food Compos Anal 2007; 20(7): 584-90.
[http://dx.doi.org/10.1016/j.jfca.2007.03.009]
[34]
Nugroho A, Heryani H, Choi JS, Park H-J. Identification and quantification of flavonoids in Carica papaya leaf and peroxynitrite-scavenging activity. Asian Pac J Trop Biomed 2017; 7(3): 208-13.
[http://dx.doi.org/10.1016/j.apjtb.2016.12.009]
[35]
Shukor MS, Shukor MY. Molecular docking and dynamics studies show phytochemicals from papaya leaves extracts as potent inhibitors of SARS–CoV–2 proteins targets and TNF–alpha and alpha thrombin: A potential holistic weapon in combating COVID–19. AIMS Mol Sci 2022; 10(3): 213-62.
[36]
Rahayu SE, Leksono AS, Gama ZP, Tarno H. The active compounds composition and antifeedant activity of leaf extract of two cultivar Carica papaya L. on Spodoptera litura F. Larvae. AIP Conf Proc 2020; 2231: 040085.
[http://dx.doi.org/10.1063/5.0002677]
[37]
Mahdian S, Zarrabi M, Panahi Y, Dabbagh S. Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations. Inform Med Unlocked 2021; 23: 100541.
[38]
Pandey SC, Jha A, Kumar A, Samant M. Evaluation of antileishmanial potential of computationally screened compounds targeting DEAD-box RNA helicase of Leishmania donovani. Int J Biol Macromol 2019; 121: 480-7.
[http://dx.doi.org/10.1016/j.ijbiomac.2018.10.053] [PMID: 30321635]
[39]
Vijayakumar BG, Ramesh D, Joji A, Jayachandra Prakasan J, Kannan T. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. Eur J Pharmacol 2020; 886: 173448.
[http://dx.doi.org/10.1016/j.ejphar.2020.173448] [PMID: 32768503]
[40]
Pawlotsky JM, Chevaliez S, McHutchison JG. The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology 2007; 132(5): 1979-98.
[http://dx.doi.org/10.1053/j.gastro.2007.03.116] [PMID: 17484890]
[41]
Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 2020; 75(11): 2829-45.
[http://dx.doi.org/10.1111/all.14429] [PMID: 32496587]
[42]
Gowrishankar S, Muthumanickam S, Kamaladevi A, et al. Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 - An in silico study. Food Chem Toxicol 2021; 148: 111966.
[http://dx.doi.org/10.1016/j.fct.2020.111966] [PMID: 33412235]
[43]
Khaerunnisa S, Kurniawan H, Awaluddin R, Suhartati S, Soetjipto S. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints 2020; 2020; 2020030226.
[44]
Bedi PS, Bekele M, Gure G. Phyto-chemistry and pharmacological activities of Hibiscus sabdariffa Linn.—A review. Int Res J Pure Appl Chem 2020; 21: 41-54.
[http://dx.doi.org/10.9734/irjpac/2020/v21i2330301]
[45]
Wang J, Yang G, Zhang L, et al. Berbamine hydrochloride inhibits bovine viral diarrhea virus replication via interfering in late-stage autophagy. Virus Res 2022; 321: 198905.
[http://dx.doi.org/10.1016/j.virusres.2022.198905] [PMID: 36064041]
[46]
Pendyala B, Patras A. in silico Screening of Food Bioactive Compounds to Predict Potential Inhibitors of COVID-19 Main protease (Mpro) and RNA-dependent RNA polymerase (RdRp). Agriculture and Food Chemistry 2020.

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy